Eisai
4523.T
#2112
Rank
โ‚น822.91 B
Marketcap
โ‚น2,919
Share price
0.79%
Change (1 day)
19.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น81.70. an increase over its 2024 EPS that were of โ‚น92.11.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น103.0211.85%
2024โ‚น92.11-32.63%
2023โ‚น136.725.52%
2022โ‚น129.56-74.01%
2021โ‚น498.47-66.58%
2020โ‚น1,49198.24%
2019โ‚น752.2717.01%
2018โ‚น642.9037.78%
2017โ‚น466.63-27.62%
2016โ‚น644.7135.33%
2015โ‚น476.40-2.82%
2014โ‚น490.23-27.66%
2013โ‚น677.72-27.49%
2012โ‚น934.70-12.67%
2011โ‚น1,07088.08%
2010โ‚น569.09-11.06%
2009โ‚น639.88-390.15%
2008-โ‚น220.54-127.78%
2007โ‚น793.9711.78%
2006โ‚น710.324.38%
2005โ‚น680.547.4%
2004โ‚น633.6743.03%
2003โ‚น443.0525.09%
2002โ‚น354.1852.67%
2001โ‚น231.9869.76%
2000โ‚น136.66